Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2•4 mg for weight management: a randomised, controlled, phase 1b trial
Cagrilintide is a long-acting amylin analogue, and semaglutide 2•4 mg is a glucagon-like peptide-1 analogue. Both the drugs have been investigated as options for...